Carlos R. Lazo

Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo

Kelly M. Lohr, Alison I. Bernstein, Kristen A. Stout et al. · Proceedings of the National Academy of Sciences · 2014 · 239 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Traumatic Brain Injury in Adult Rats Causes Progressive Nigrostriatal Dopaminergic Cell Loss and Enhanced Vulnerability to the Pesticide Paraquat

Ché B. Hutson, Carlos R. Lazo, Farzad Mortazavi et al. · Journal of Neurotrauma · 2011 · 130 citations

Pharmacy, Neurobiology, Neuroscience +17

Adenosine A2A receptor antagonism reverses inflammation-induced impairment of microglial process extension in a model of Parkinson's disease

Stefka Gyoneva, Lauren P. Shapiro, Carlos R. Lazo et al. · Neurobiology of Disease · 2014 · 97 citations · Full text

Life Sciences, Neuroscience, Pharmacology +16

Exposure to the polybrominated diphenyl ether mixture DE-71 damages the nigrostriatal dopamine system: Role of dopamine handling in neurotoxicity

Joshua M. Bradner, Tiffany A. Suragh, Wendy Wilson et al. · Experimental Neurology · 2012 · 62 citations · Full text

Pharmacy, Neuroscience, Toxicology +10

RING finger protein 11 (RNF11) modulates susceptibility to 6-OHDA-induced nigral degeneration and behavioral deficits through NF-κB signaling in dopaminergic cells

Elaine L. Pranski, Nirjari V. Dalal, Carson Van Sanford et al. · Neurobiology of Disease · 2013 · 15 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17